News
HNGZY
4.000
NaN%
--
Weekly Report: what happened at HNGZY last week (0609-0613)?
Weekly Report · 5d ago
Weekly Report: what happened at HNGZY last week (0602-0606)?
Weekly Report · 06/09 12:26
Weekly Report: what happened at HNGZY last week (0526-0530)?
Weekly Report · 06/02 12:39
abrdn Emerging Markets Dividend Active ETF Q1 2025 Commentary
Seeking Alpha · 05/29 11:35
Weekly Report: what happened at HNGZY last week (0519-0523)?
Weekly Report · 05/26 12:38
Weekly Report: what happened at HNGZY last week (0512-0516)?
Weekly Report · 05/19 12:24
Weekly Report: what happened at HNGZY last week (0505-0509)?
Weekly Report · 05/12 12:24
Weekly Report: what happened at HNGZY last week (0428-0502)?
Weekly Report · 05/05 12:27
Weekly Report: what happened at HNGZY last week (0421-0425)?
Weekly Report · 04/28 12:42
Weekly Report: what happened at HNGZY last week (0414-0418)?
Weekly Report · 04/21 12:41
Weekly Report: what happened at HNGZY last week (0407-0411)?
Weekly Report · 04/14 12:24
Weekly Report: what happened at HNGZY last week (0331-0404)?
Weekly Report · 04/07 12:24
Weekly Report: what happened at HNGZY last week (0324-0328)?
Weekly Report · 03/31 12:42
Weekly Report: what happened at HNGZY last week (0317-0321)?
Weekly Report · 03/24 12:24
Weekly Report: what happened at HNGZY last week (0310-0314)?
Weekly Report · 03/17 12:40
Weekly Report: what happened at HNGZY last week (0303-0307)?
Weekly Report · 03/10 12:42
Weekly Report: what happened at HNGZY last week (0224-0228)?
Weekly Report · 03/03 12:40
Weekly Report: what happened at HNGZY last week (0217-0221)?
Weekly Report · 02/24 12:41
Weekly Report: what happened at HNGZY last week (0210-0214)?
Weekly Report · 02/17 12:36
Weekly Report: what happened at HNGZY last week (0203-0207)?
Weekly Report · 02/10 12:26
More
Webull provides a variety of real-time HNGZY stock news. You can receive the latest news about Hangzhou Tigerme through multiple platforms. This information may help you make smarter investment decisions.
About HNGZY
Hangzhou Tigermed Consulting Co Ltd is a China-based holding company engaged in providing clinical trial services for research and development of new drugs. The Company operates two segments. The Clinical Trial Solutions segment provides clinical trial operation services and medical translation services to biopharmaceutical and medical device companies and thus help them conduct clinical trials of innovative drugs, generic drugs and medical devices. The Clinical-Related and Laboratory Services segment is involved in provision of analytical services, such as data management and statistical analysis; logistics and execution support services, such as clinical trial site management; administrative assistance, such as patient recruitment; as well as consulting services. This segment also provides laboratory services for preclinical and clinical development stages through its subsidiary. The Company conducts its businesses in the domestic and overseas markets.